| 000 | 01808 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250512002826.0 | ||
| 264 | 0 | _c19890908 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0004-8291 | ||
| 024 | 7 |
_a10.1111/j.1445-5994.1989.tb00233.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarks, D I | |
| 245 | 0 | 0 |
_aDiffuse large cell lymphoma: a teaching hospital experience. _h[electronic resource] |
| 260 |
_bAustralian and New Zealand journal of medicine _cApr 1989 |
||
| 300 |
_a159-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAntigens, CD |
| 650 | 0 | 4 | _aAntigens, CD19 |
| 650 | 0 | 4 | _aAntigens, CD20 |
| 650 | 0 | 4 |
_aAntigens, Differentiation _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCell Adhesion Molecules |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHospitals, Teaching |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLectins |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeprilysin |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aSialic Acid Binding Ig-like Lectin 2 |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aSheridan, W P | |
| 700 | 1 | _aEllis, D W | |
| 700 | 1 | _aBoyd, A W | |
| 700 | 1 | _aMorstyn, G | |
| 700 | 1 | _aGreen, M D | |
| 700 | 1 | _aFox, R M | |
| 773 | 0 |
_tAustralian and New Zealand journal of medicine _gvol. 19 _gno. 2 _gp. 159-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1445-5994.1989.tb00233.x _zAvailable from publisher's website |
| 999 |
_c2481104 _d2481104 |
||